We could not find any results for:
Make sure your spelling is correct or try broadening your search.
- Paragraph IV Litigation Underway - MORRISTOWN, N.J., Jan. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading global specialty pharmaceutical company, today confirmed...
MORRISTOWN, N.J., Dec. 14 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) today announced a new program encouraging health professionals to help maintain the bone health of...
- Paragraph IV Litigation Underway - MORRISTOWN, N.J., Dec. 4 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading global specialty pharmaceutical company, today confirmed...
MORRISTOWN, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and...
CORONA, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that its subsidiary Watson Laboratories...
MORRISTOWN, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals (NYSE:WPI), a leader in generic and specialty branded pharmaceuticals, announced today that G. Frederick Wilkinson has...
MORRISTOWN, N.J., Aug. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories...
MORRISTOWN, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories...
MORRISTOWN, N.J., July 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leader in generic and specialty branded pharmaceuticals, today announced a license agreement with...
MORRISTOWN, N.J., July 27 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leader in generic and specialty branded pharmaceuticals, announced that effective today Mark W...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.235 | 5.88235294118 | 3.995 | 4.525 | 3.995 | 278 | 4.29883784 | DE |
4 | 0.625 | 17.3370319001 | 3.605 | 4.525 | 3.435 | 386 | 3.97186175 | DE |
12 | 0.49 | 13.1016042781 | 3.74 | 4.525 | 3.3 | 398 | 3.86211505 | DE |
26 | -0.84 | -16.5680473373 | 5.07 | 5.29 | 3.3 | 438 | 4.04768245 | DE |
52 | -1.32 | -23.7837837838 | 5.55 | 6.35 | 3.3 | 326 | 4.60369853 | DE |
156 | -2.47 | -36.8656716418 | 6.7 | 7.2 | 3.3 | 331 | 5.23899845 | DE |
260 | -2.47 | -36.8656716418 | 6.7 | 7.2 | 3.3 | 331 | 5.23899845 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions